Jeremy Skillington

At-a-Glance

Serves as Chief Executive Officer at Poolbeg Pharma.
Co-founded a cancer immunotherapy company.
Served as VP BD at Inflazome, which was acquired by Roche in 2020.
Possesses 20 years of experience building companies, leading due-diligence, licensing, and developing collaborations.
Holds a PhD in Cell and Molecular Biology.

Biography

Jeremy Skillington serves as the Chief Executive Officer at Poolbeg Pharma. He is a biotechnology entrepreneur and a senior management executive with over 20 years of experience in company building, business development, and strategic collaborations.

Prior to his role at Poolbeg Pharma, Mr. Skillington was the VP BD at Inflazome, which was acquired by Roche in 2020. He also co-founded a cancer immunotherapy company and has managed business development at multiple startups.